{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:19:29Z","timestamp":1790795969509,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bioorg.2022.106144","type":"journal-article","created":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T17:46:47Z","timestamp":1662918407000},"page":"106144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies"],"prefix":"10.1016","volume":"129","author":[{"given":"Bushra","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda","family":"Abida Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Aziz-ur-Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Mohammad Kashif Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshab","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.106144_b0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ph13030036","article-title":"Bioisosteric replacement as a tool in anti-HIV drug design","volume":"13","author":"Dick","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106144_b0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14756366.2021.1908277","article-title":"Utility of novel 2-furanones in synthesis of other heterocyclic compounds having anti-inflammatory activity with dual COX-2\/LOX inhibition","volume":"36","author":"Abd El-Hameed","year":"2021","journal-title":"J. Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40709-021-00141-w","article-title":"Investigating the effects of two novel 4-MMPB analogs as potent lipoxygenase inhibitors for prostate cancer treatment","volume":"28","author":"Iranpour","year":"2021","journal-title":"J. Biol. Res.-Thessaloniki"},{"key":"10.1016\/j.bioorg.2022.106144_b0020","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1002\/cphc.201300629","article-title":"On the regio- and stereospecificity of arachidonic acid peroxidation catalyzed by mammalian 15-lipoxygenases, a combined molecular dynamics and QM\/MM study","volume":"14","author":"Suard\u00edaz","year":"2013","journal-title":"Chem. Phy. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.106144_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543776.2016.1113259","article-title":"15-Lipoxygenase inhibitors, a patent review","volume":"26","author":"Sadeghian","year":"2016","journal-title":"Expert Opinion Ther. Pat."},{"key":"10.1016\/j.bioorg.2022.106144_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113457","article-title":"Novel 1,2,4-triazine-quinoline hybrids: the privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition","volume":"219","author":"Ghanim","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0035","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1016\/j.jscs.2013.02.006","article-title":"Ejaz, Synthesis of new N-(5-chloro-2-methoxyphenyl)-4-(5-substituted-1,3,4-oxadiazol-2-ylthio)butanamide derivatives as suitable lipoxygenase inhibitors","volume":"20","author":"Aziz-ur-Rehman","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2022.106144_b0040","doi-asserted-by":"crossref","first-page":"11020152","DOI":"10.3390\/biom11020152","article-title":"Lipoxygenase inhibition by plant extracts","volume":"11","author":"Loncaric","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106144_b0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14756366.2020.1742116","article-title":"Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-lipoxygenase inhibitors","volume":"35","author":"Ali","year":"2020","journal-title":"J. Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ddr.21787","article-title":"Design, synthesis, and structure-activity relationship study of o-prenylated 3-acetylcoumarins as potent inhibitors of soybean 15-lipoxygenase","volume":"82","author":"Zerangnasrabad","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2022.106144_b0055","first-page":"1","article-title":"Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review","volume":"13","author":"Tahlan","year":"2019","journal-title":"Bio. Med. Cent. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0060","first-page":"14170","article-title":"Benefits and applications of microwave-assisted synthesis of nitrogen containing heterocycles in medicinal chemistry","volume":"10","author":"Henary","year":"2020","journal-title":"Royal Soc. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0065","first-page":"44247","article-title":"Prescribed drugs containing nitrogen heterocycles","volume":"10","author":"Heravi","year":"2020","journal-title":"Royal Soc. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.106144_b0070","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1021\/acsaem.0c01769","article-title":"4H-[1,2,3]Triazolo[4,5-c][1,2,5]oxadiazole 5-oxide and its salts: promising multipurpose energetic materials","volume":"3","author":"Voronin","year":"2020","journal-title":"ACS App. Ener. Mat."},{"key":"10.1016\/j.bioorg.2022.106144_b0075","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1021\/acs.jmedchem.8b00876","article-title":"From oxiranes to oligomers: architectures of US FDA approved pharmaceuticals containing oxygen heterocycles","volume":"61","author":"Delost","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.115443","article-title":"Design, synthesis and characterization of \u03c0-conjugated 2,5-diphenylsubstituted-1,3,4-oxadiazole-based D-\u03c0-A-\u03c0\u02b9-D\u2032 form of efficient deep blue functional materials: photophysical properties and fluorescence \u201cturn-off\u201d chemsensors approach","volume":"328","author":"Najare","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2022.106144_b0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jtice.2020.12.011","article-title":"Pyridine based N-heterocyclic compounds as aqueous phase corrosion inhibitors: a review","volume":"117","author":"Verma","year":"2020","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.bioorg.2022.106144_b0090","doi-asserted-by":"crossref","first-page":"14050438","DOI":"10.3390\/ph14050438","article-title":"Synthesis and anticancer evaluation of new 1,3,4-oxadiazole derivatives","volume":"14","author":"Stecoza","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2022.106144_b0095","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1002\/anie.202014207","article-title":"1,3,4-Oxadiazole bridges: a strategy to improve energetics at the molecular level","volume":"60","author":"Ma","year":"2021","journal-title":"Ang. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2022.106144_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115888","article-title":"Synthetic approaches to unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles and their MAO-B inhibitory activity","volume":"29","author":"Karabelyov","year":"2021","journal-title":"Bio. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127995","article-title":"Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus","volume":"41","author":"Wang","year":"2021","journal-title":"Bio. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106144_b0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/cbdd.13795","article-title":"1,3,4-Oxadiazole and its derivatives: a review on recent progress in anticancer activities","volume":"97","author":"Vaidya","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2022.106144_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104558","article-title":"Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents","volume":"108","author":"Mansouri","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129250","article-title":"Crystal structure and spectroscopy properties of new Pt II complexes containing 5-alkyl-1,3,4-oxadiazol-2-thione derivatives","volume":"1226","author":"Souza","year":"2021","journal-title":"J. Mol. Str."},{"issue":"5","key":"10.1016\/j.bioorg.2022.106144_b0125","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11696-019-01012-4","article-title":"Design, synthesis, and biological evaluation of novel pyrethrin derivatives containing 1,3,4-oxadiazole and thioether moieties as active insecticidal agents","volume":"74","author":"Yang","year":"2020","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2022.106144_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127842","article-title":"Indolyl-\u03b1-keto-1,3,4-oxadiazoles: synthesis, anti-cell proliferation activity, and inhibition of tubulin polymerization","volume":"37","author":"Tantak","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.106144_b0135","first-page":"575","article-title":"Design and synthesis of novel 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]1,3,4-thiadiazole derivatives and their antimicrobial studies","volume":"5","author":"Triloknadh","year":"2018","journal-title":"Eur. J. Bio."},{"key":"10.1016\/j.bioorg.2022.106144_b0140","first-page":"1","article-title":"Design, synthesis and in vitro characterization of novel antimicrobial agents based on 6-chloro-9H-carbazol derivatives and 1,3,4-oxadiazole scaffolds","volume":"25","author":"Telehoiu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2022.106144_b0145","article-title":"New quinoxalin-1,3,4-oxadiazole derivatives: synthesis, characterization, in vitro biological evaluations, and molecular modeling studies","volume":"2","author":"Mirzazadeh","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2022.106144_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104922","article-title":"Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer\u2019s disease","volume":"111","author":"Choubey","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0155","doi-asserted-by":"crossref","first-page":"13110390","DOI":"10.3390\/ph13110390","article-title":"Synthesis of new 1,3,4-oxadiazole-incorporated 1,2,3-triazole moieties as potential anticancer agents targeting thymidylate synthase and their docking studies","volume":"13","author":"Alam","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2022.106144_b0160","first-page":"22688","article-title":"Synthesis and biological evaluation of a new series of benzofuran-1,3,4-oxadiazole containing 1,2,3-triazole-acetamides as potential \u03b1-glucosidase inhibitors","volume":"35","author":"Abedinifar","year":"2021","journal-title":"J. Biomol. Toxi."},{"key":"10.1016\/j.bioorg.2022.106144_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104638","article-title":"Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of \u03b1-glucosidase enzyme along with in silico study","volume":"108","author":"Alomari","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103852","article-title":"Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition","volume":"99","author":"Javid","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104920","article-title":"Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV","volume":"112","author":"Hofny","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"44","key":"10.1016\/j.bioorg.2022.106144_b0180","first-page":"14210","article-title":"Evaluation of ethylated phenylcarbamoylazinane-1,2,4-triazole amides derivatives as 15-lipoxygenase inhibitors together with cytotoxic, ADME and molecular modeling studies","volume":"5","author":"Muzaffar","year":"2020","journal-title":"ChemSelect"},{"key":"10.1016\/j.bioorg.2022.106144_b0185","doi-asserted-by":"crossref","first-page":"105261","DOI":"10.1016\/j.bioorg.2021.105261","article-title":"Exploring phenylcarbamoylazinane-1, 2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies","volume":"115","author":"Shahid","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0190","doi-asserted-by":"crossref","first-page":"104525","DOI":"10.1016\/j.bioorg.2020.104525","article-title":"Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies","volume":"107","author":"Muzaffar","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2022.106144_b0195","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4314\/tjpr.v15i7.22","article-title":"Preliminary structure-activity relationship studies on some novel s-substituted aliphatic analogues of 5-{1-[(4-chlorophenyl)sulfonyl]-3-piperidinyl}-1,3,4-oxadiazol-2-ylsulfide","volume":"15","author":"Nafeesa","year":"2016","journal-title":"Trop. J. Pharm. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2022.106144_b0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/14756366.2010.550890","article-title":"Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity","volume":"26","author":"Akhter","year":"2011","journal-title":"J. Enz. Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2022.106144_b0205","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.4067\/S0717-97072013000400061","article-title":"Synthesis, structural characterization and enzyme inhibition studies on 5-(2-nitrostyryl)-1,3,4-oxadiazole-2-thiol derivatives","volume":"58","author":"Abbasi","year":"2013","journal-title":"J. Chilean Chem. Soc."},{"key":"10.1016\/j.bioorg.2022.106144_b0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bioorg.2019.02.043","article-title":"Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2\/15-LOX inhibitors: Design, synthesis and docking studies","volume":"85","author":"Youssif","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105243","article-title":"Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and computational studies","volume":"115","author":"Bashir","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"1-3","key":"10.1016\/j.bioorg.2022.106144_b0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Del. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2022.106144_b0225","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.106144_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106144_b0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1271\/bbb.58.421","article-title":"An assay for lipoxygenase activity by chemiluminescence","volume":"58","author":"Kondo","year":"1994","journal-title":"Biosci. Biotech. Biochem."},{"key":"10.1016\/j.bioorg.2022.106144_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115605","article-title":"Indole acrylonitriles as potential anti-hyperglycemic agents: synthesis, \u03b1-glucosidase inhibitory activity and molecular docking studies","volume":"28","author":"Solangi","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106144_b0245","unstructured":"M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G.A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zheng, J.L. Sonnenberg, M. Hada, M. Ehara, K.Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J.A. Montgomery Jr., J.E. Peralta, F. Ogliaro, M.J. Bearpark, J. Heyd, E.N. Brothers, K.N. Kudin, V.N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A.P. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N.J. Millam, M. Klene, J.E. Knox, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, R.L. Martin, K. Morokuma, V.G. Zakrzewski, G.A. Voth, P. Salvador, J.J. Dannenberg, S. Dapprich, A.D. Daniels, O. Farkas, J.B. Foresman, J.V. Ortiz, J. Cioslowski, D.J. Fox, Gaussian 09 (D01), Inc., Wallingford, CT, USA (2010)."},{"key":"#cr-split#-10.1016\/j.bioorg.2022.106144_b0250.1","unstructured":"MOE, Molecular operating environment (MOE), 2014.09"},{"key":"#cr-split#-10.1016\/j.bioorg.2022.106144_b0250.2","unstructured":"Chemical computing group Inc., 1010 Sherbooke St. West, Montreal, QC, Canada, 2014 (2016)."},{"key":"10.1016\/j.bioorg.2022.106144_b0255","unstructured":"GaussView version 5 K.R. Dennington, T. Keith, J. Millam-Semichem Inc., Shawnee Mission, GaussView (2009) version 5."},{"key":"10.1016\/j.bioorg.2022.106144_b0260","doi-asserted-by":"crossref","unstructured":"W. Shahid, S.A. Ejaz, M. al-Rashida, M. Saleem, M. Ahmed, J. Rahman, N. Riaz, M. Ashraf, Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies, Bioorg. Chem. 110 (2021) 104818.","DOI":"10.1016\/j.bioorg.2021.104818"},{"key":"10.1016\/j.bioorg.2022.106144_b0265","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: A multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comp. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822005508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822005508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:37:03Z","timestamp":1758616623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822005508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"alternative-id":["S0045206822005508"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106144","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106144"}}